FindTrial
Sign In

Establishment and Characterization of Patient-Derived Organoid (PDO) Models of Solid Tumors

Establishment and Characterization of Patient-Derived Organoid (PDO) Models of Solid Tumors

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500110775
Enrollment
Unknown
Registered
2025-10-20
Start date
2025-10-20
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Solid tumors

Interventions

Observation group:None

Sponsors

Peking University Shenzhen Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1?The disease type is a solid tumor that has been pathologically diagnosed. 2?Age over 18 years old.

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

MeasureTime frame
The consistency between drug sensitivity and patient efficacy;—

Countries

China

Contacts

Public ContactJing Gao

Peking University Shenzhen Hospital

gaojing_pumc@163.com+86 13581565966

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026